Submitted by Anonymous (not verified) on 22 July 2026 - 11:02
Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 28, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 28, Status: Authorised